KOREA WHO
-
-
-
Co-CEO of Lotte Biologics
Shin Yu-yeol
Lotte Heir Shin Yu-yeol Faces Biopharma Test
-
Last Updated on Mar 20, 2026
-
Co-CEO of Lotte Biologics
Life Summary
Shin Yu-yeol is a co-CEO and Vice President of Lotte Biologics. He also serves as Head of the Future Growth Office at Lotte Corporation.
As the son of Lotte Group Chairman Shin Dong-bin, he is the management successor who will lead Lotte Group. He has been tasked with discovering new growth engines for Lotte Group, with a focus on future businesses.
He was born on March 30, 1986, when Chairman Shin Dong-bin was working at Nomura Securities' London branch. He is a Japanese national, and his Japanese name is Shigemitsu Satoshi.
He attended the elementary, middle, and high school divisions of Aoyama Gakuin, a private school in Japan, and graduated from the Department of Environmental Information in the Faculty of Commerce at Keio University in Japan. He completed an MBA program at Columbia Business School in the United States.
He began his professional career at Nomura Securities in Japan. In 2020, he joined Lotte Japan as Head of the Sales Division and began his management training.
In 2008, he was appointed CEO of Lotte Strategic Investment (LSI), the largest shareholder of Lotte Financial. He later served as CEO of Lotte Financial.
He served as Managing Director of the Tokyo branch for basic materials at Lotte Chemical Japan, Head of the Future Growth Office at Lotte Corporation, and Executive Director and Head of the Global Strategy Office at Lotte Biologics. From this point, he began to expand his presence in Korea's Lotte Group in earnest.
He was appointed as an inside director of Lotte Holdings Japan and was promoted to Vice President at Lotte Corporation and Lotte Biologics. In November 2025, he was appointed CEO of Lotte Biologics.
Having lived almost entirely in Japan until he turned 40, he does not speak Korean fluently, but he is able to communicate. After turning 38, he was exempted from mandatory military service, and speculation is widespread that he will soon acquire South Korean nationality.
The original text may need clarification in this part: “In 2008, he was appointed CEO of Lotte Strategic Investment (LSI)…” Given the surrounding timeline, the year may be a typo or may require fact-checking in the source text.
#ShinYu-yeol #LotteBiologics #LotteGroup #ShinDong-bin #LotteCorporation #futuregrowth #managementsuccessor #JapanKorea #biopharma #corporateleadership
As the son of Lotte Group Chairman Shin Dong-bin, he is the management successor who will lead Lotte Group. He has been tasked with discovering new growth engines for Lotte Group, with a focus on future businesses.
He was born on March 30, 1986, when Chairman Shin Dong-bin was working at Nomura Securities' London branch. He is a Japanese national, and his Japanese name is Shigemitsu Satoshi.
He attended the elementary, middle, and high school divisions of Aoyama Gakuin, a private school in Japan, and graduated from the Department of Environmental Information in the Faculty of Commerce at Keio University in Japan. He completed an MBA program at Columbia Business School in the United States.
He began his professional career at Nomura Securities in Japan. In 2020, he joined Lotte Japan as Head of the Sales Division and began his management training.
In 2008, he was appointed CEO of Lotte Strategic Investment (LSI), the largest shareholder of Lotte Financial. He later served as CEO of Lotte Financial.
He served as Managing Director of the Tokyo branch for basic materials at Lotte Chemical Japan, Head of the Future Growth Office at Lotte Corporation, and Executive Director and Head of the Global Strategy Office at Lotte Biologics. From this point, he began to expand his presence in Korea's Lotte Group in earnest.
He was appointed as an inside director of Lotte Holdings Japan and was promoted to Vice President at Lotte Corporation and Lotte Biologics. In November 2025, he was appointed CEO of Lotte Biologics.
Having lived almost entirely in Japan until he turned 40, he does not speak Korean fluently, but he is able to communicate. After turning 38, he was exempted from mandatory military service, and speculation is widespread that he will soon acquire South Korean nationality.
The original text may need clarification in this part: “In 2008, he was appointed CEO of Lotte Strategic Investment (LSI)…” Given the surrounding timeline, the year may be a typo or may require fact-checking in the source text.
#ShinYu-yeol #LotteBiologics #LotteGroup #ShinDong-bin #LotteCorporation #futuregrowth #managementsuccessor #JapanKorea #biopharma #corporateleadership